Copyright
©2012 Baishideng Publishing Group Co.
World J Radiol. Oct 28, 2012; 4(10): 421-430
Published online Oct 28, 2012. doi: 10.4329/wjr.v4.i10.421
Published online Oct 28, 2012. doi: 10.4329/wjr.v4.i10.421
Older applications | Recent applications | Evolving applications for routine use | Commonly employed modality in current practice | |
Chamber orientation | + | +/- | - | Echocardiogram |
Chamber size | + | +/- | - | Echocardiogram |
Rhythm abnormalities | + | - | - | Electrophysiologic studies |
Global EF | ++ | ++ | Contrast angiogram, 2D echocardiogram | |
Regional EF | ++ | ++ | MUGA | |
Wall motion abnormalities | ++ | +/- | - | Gated myocardial perfusion scans |
Diastolic function evaluation | - | + | ++ | Echo-Doppler with E/A measurements |
Assessment of synchrony | - | - | ++ | Speckle tracking echocardiogram |
Baseline MUGA (before starting of chemotherapy or before 100 mg/m2 dose | If LVEF is ≤ 30% - no doxorubicin |
If baseline LVEF is > 30% and < 50% | MUGA to perform before each dose |
If baseline LVEF is ≥ 50% | MUGA to perform at the dose of 250-300 mg/m2, 400-450 mg/m2 and thereafter before each higher dose |
If the fall of LVEF from previous study is ≥ 10% or if LVEF is ≤ 30% | Discontinue doxorubicin |
If mediastinal irradiation is < 1000 cGy | Perform echocardiogram every alternate dose of doxorubicin when dose is < 300 mg/m2 and perform echocardiogram before each dose if the dose of chemotherapeutic agent is ≥ 300 mg/m2 |
If mediastinal irradiation is > 1000 cGy | Perform echocardiogram before each dose |
When the cumulative dose of chemotherapy crosses 400 mg/m2 | Perform MUGA before any additional dose |
Discontinue doxorubicin | If the fall of LVEF is ≥ 10% from previous study or LVEF is < 55% |
Follow up | MUGA at 1st year of completion of therapy and then echocardiogram yearly till next 3 years and a repeat MUGA at 5th year along with electrocardiogram yearly |
- Citation: Mitra D, Basu S. Equilibrium radionuclide angiocardiography: Its usefulness in current practice and potential future applications. World J Radiol 2012; 4(10): 421-430
- URL: https://www.wjgnet.com/1949-8470/full/v4/i10/421.htm
- DOI: https://dx.doi.org/10.4329/wjr.v4.i10.421